Screening Is Not Diagnosis

A screen positive result is not automatically a final diagnosis. It may mean that a marker was detected, a threshold was crossed or further assessment is advised. The exact meaning varies between programmes, so the result letter and follow up pathway matter.

Screening and diagnosis ask different questions Screening proactively tests people who generally have no symptoms of the target condition. It aims to identify a higher chance, early finding or risk marker within a defined population. Diagnosis investigates whether a particular condition explains symptoms, signs, an abnormal result or another clinical concern. Diagnostic assessment can also occur before symptoms develop, so symptoms alone do not define the difference. The main distinction is the reason and setting for testing. Screening begins with a programme offer, while diagnostic testing begins with an individual clinical question. The title is a practical rule, not an absolute law A screen positive result should not automatically be treated as a complete diagnosis. Many programmes require another test, assessment or period of monitoring before the person's condition is fully classified. However, screening programmes do not all work in the same way. Some screening examinations can directly identify and measure a condition that then enters surveillance or treatment. Abdominal aortic aneurysm screening is an example. The ultrasound measurement can show that an aneurysm is present and determine whether monitoring or vascular referral follows. The safer rule is to interpret the result according to the exact programme. Do not assume that every positive result confirms disease or that every result needs one separate confirmatory test. Result words differ between programmes Programmes may use terms such as screen positive, higher chance, abnormal, referable, detected or further tests needed. These words are not interchangeable across all screening pathways. A screen positive result means that the result meets the programme's threshold for a defined next step. It does not tell you by itself how likely the target condition is. An unclear or inadequate result may mean that the sample or image could not be interpreted reliably. Repeating the screening test does not imply that disease has been found. Positive can describe different findings A bowel screening faecal immunochemical test, called FIT, detects human haemoglobin in stool. Blood was detected when the result requires further assessment, but bowel cancer has not been diagnosed. Cervical screening first checks for high risk human papillomavirus, called HPV. An HPV positive result means that HPV was detected, not that cervical cancer is present. Antenatal screening may report a higher chance of a chromosomal condition. The result provides a probability and can lead to a choice about further screening or diagnostic testing. These examples show why the target condition and measured marker must be named. The word positive alone is not enough. How likely is a positive result to represent the target condition? Positive predictive value is the proportion of people with a positive result who truly have the target condition. It answers the question that often matters most after a screen positive result. Positive predictive value depends on the test's sensitivity and specificity. It also depends strongly on how common the target condition is in the screened population. When a condition is uncommon, false positive results can form a substantial share of all positive results. This can happen even when the test performs well. There is no safe universal claim that most people with any abnormal screening result do or do not have the condition. The proportion varies by programme, threshold, screening round, age and risk group. Sensitivity is not the only design aim Sensitivity is the ability to identify people who have the target condition. Specificity is the ability to identify people who do not have it. Some programmes prioritise avoiding missed cases, but they do not simply maximise sensitivity regardless of harm. Thresholds are chosen by balancing missed conditions, false positives, follow up burden, overdiagnosis and programme benefit. Changing the threshold of the same test can often increase sensitivity while reducing specificity, or the reverse. A better test or combined pathway may improve both, so the trade off is not a universal fixed rule. Follow up does not always give immediate certainty The next step may be a repeat sample, another screening test, diagnostic imaging, endoscopy, biopsy, specialist assessment or surveillance. The programme determines which step is appropriate. A diagnostic follow up test usually provides more direct information about the clinical question. It can still be inconclusive, miss disease or reveal an uncertain finding. Further testing should therefore reduce uncertainty rather than promise complete certainty. Sometimes several results and clinical findings must be considered together. False positives can cause more than temporary worry A false positive means that the screening pathway indicates a higher chance or positive result when the target condition is not present. It is not proof that the programme made an avoidable error. False positives can cause anxiety, repeat visits, invasive procedures, complications and financial or practical burdens. These harms may be brief or may continue after the final reassuring result. Overdiagnosis is different. It means correctly detecting a condition that would never have caused symptoms or harm during the person's lifetime. Overtreatment means treating a condition when treatment provides no meaningful benefit. False positives, overdiagnosis and overtreatment can overlap within a programme but are not the same event. Screen negative results have limits A screen negative result means the programme did not identify a raised chance or finding that meets its action threshold at that time. It does not guarantee that the target condition is absent. A false negative occurs when the target condition was present but screening did not identify it. A condition that genuinely develops after screening is not automatically a false negative. Screening does not replace symptom assessment. Contact your GP practice when new, persistent or concerning symptoms develop, even after a screen negative result. What to do with a screening result Read the programme letter or digital result carefully because it should explain what was measured and what happens next. Follow the stated timeframe for repeat screening, assessment or referral. Contact the screening service when the wording, appointment or next step is unclear. Tell the clinical team about relevant symptoms because these may need a separate diagnostic pathway. Call 999 for severe breathing difficulty, collapse, abnormal unresponsiveness or heavy bleeding that will not stop. Do not delay emergency care while waiting for a screening appointment. This lesson explains general screening result principles. It cannot interpret an individual result or estimate your personal chance of a condition.

A screening result must be interpreted within its programme. It may identify a marker, probability or measured condition, but it does not automatically provide a complete diagnosis or a harmless false alarm.